Feasibility of screening for ovarian cancer using symptoms as selection criteria

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 1, 2007, Pages 59-64

  Rufford, B D ^a   Jacobs, I J ^b   Menon, U ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CA125; Ovarian cancer; Screening; Symptoms; Ultrasound

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER DISEASE; BRENNER TUMOR; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CYSTADENOMA; ENDOMETRIAL DISEASE; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; OVARY CANCER; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; AGED; CA-125 ANTIGEN; FAMILY PRACTICE; FEASIBILITY STUDIES; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; OVARIAN CYSTS; OVARIAN NEOPLASMS; PATIENT SELECTION; PILOT PROJECTS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 33845526979     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01153.x     Document Type: Article

References (17)

1. Teneriello MG, Park RC. Early detection of ovarian cancer. CA Cancer J Clin 1995;45:71-87.
2. Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005;193:1630-9.
3. Wikborn C, Pettersson F, Silfversward C, Moberg PJ. Symptoms and diagnostic difficulties in ovarian epithelial cancer. Int J Gynaecol Obstet 1993;42:261-4.
4. Petignat P, Gaudin G, Vajda D, Joris F, Obrist R. Ovarian cancer: the symptoms and pathology. The cases of the Cantonal Cancer Registry (1989-1995). Schweiz Med Wochenschr 1997;127:1993-9.
5. Flam F, Einhorn N, Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1988;27:53-7.
6. Smith EM, Anderson B. The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer 1985;56:2727-32.
7. Wikborn C, Pettersson F, Moberg PJ. Delay in diagnosis of epithelial ovarian cancer. Int J Gynaecol Obstet 1996;52:263-7.
8. Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis. Cancer 2000;89:2068-75.
9. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004;291:2705-12.
10. Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer. Obstet Gynecol 2001;98:212-17.
11. Smith LH, Morris CR, Yasmeen S, Parikh-Patel A, Cress RD, Romano PS. Ovarian cancer: can we make the clinical diagnosis earlier? Cancer 2005;104:1398-407.
12. Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol 2001;83:466-71.
13. Vine MF, Calingaert B, Berchuck A, Schildkraut JM. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol 2003;90:75-82.
14. Webb PM, Purdie DM, Grover S, Jordan S, Dick ML, Green AC. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol 2004;92:232-9.
15. Nelson L, Ekbom A, Gerdin E. Ovarian cancer in young women in Sweden, 1989-1991. Gynecol Oncol 1999;74:472-6.
16. Cancer Registration Statistics. 2003. Office of National Statistics, London, UK, 2003.
17. Smith-Bindman R, Weiss E, Feldstein V. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol 2004;24:558-65.